Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

AN ACTION-PACKED week on Wall Street ends with a bang as index-tracking funds are set to reshuffle US$250 billion of shares, ...

Mizuho desk-based analyst Jordan Klein agreed that the latest move and commentary from the Fed "created more confidence in a soft-landing scenario," which he said could be interpreted positively for ...

General Motors has recalled nearly 450,000 vehicles equipped with indicators which don't promptly warn drivers when brake fluid levels are too low.